EV/EBITDA:
-6.300.00(0.00%)Summary
- As of today (September 16, 2025), APGE EV/EBITDA is -6.30, unchanged {tradingSession}.
- Over the past year, APGE EV/EBITDA has increased by +9.34 (+59.72%).
- APGE EV/EBITDA is now -25.50% below its all-time high of -5.02.
Performance
APGE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
APGE EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | 0.0% | -0.1% | -0.1% |
| 1 m1 month | +1.6% | -1.6% | -1.2% |
| 3 m3 months | +23.3% | -14.2% | -13.5% |
| 6 m6 months | +24.6% | -6.1% | -7.8% |
| ytdytd | +37.6% | -22.2% | -18.7% |
| 1 y1 year | +59.7% | -24.3% | -28.5% |
| 5 y5 years | - | - | - |
APGE EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -6.12 | -2.9% | -6.66 | +5.4% |
| 3 m | 3-month | -5.81 | -8.4% | -8.64 | +27.1% |
| 6 m | 6-month | -5.02 | -25.5% | -8.67 | +27.3% |
| 1 y | 1-year | -5.02 | -25.5% | -18.96 | +66.8% |
| 3 y | 3-year | -5.02 | -25.5% | -38.03 | +83.4% |
| 5 y | 5-year | -5.02 | -25.5% | -38.03 | +83.4% |
| alltime | all time | -5.02 | -25.5% | -38.03 | +83.4% |
APGE EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -6.30(-37.6%) |
| Date | Value |
|---|---|
| 2024 | -10.09(-2.5%) |
| 2023 | -10.35 |
FAQ
- What is Apogee Therapeutics, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Apogee Therapeutics, Inc.?
- What is APGE EV/EBITDA year-to-date change?
- What is Apogee Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Apogee Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of APGE is -6.30
What is the all time high EV/EBITDA for Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. all-time high EV/EBITDA is -5.02
What is APGE EV/EBITDA year-to-date change?
Apogee Therapeutics, Inc. EV/EBITDA has changed by +3.79 (+37.56%) since the beginning of the year
What is Apogee Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, APGE EV/EBITDA has changed by +9.34 (+59.72%)